Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01523769 · ClinicalTrials.gov registry record · NA

Umbilical Cord Milking on the Reduction of Red Blood Cell Transfusion Rates in Infants

A NA study, sponsored by Eastern Virginia Medical School.

Completed
Registry status
NA
Development phase
113
Enrollment target

NCT01523769 is a NA study that has completed, run by Eastern Virginia Medical School. The registered enrollment target is 113 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01523769, a NA study, has completed, sponsored by Eastern Virginia Medical School.

COMPLETED
Registry status
NA
Development phase
113 participants
Enrollment target

Study Summary

Delayed cord clamp of at least 30 seconds in neonates under 37 weeks has shown that these infants have higher circulating blood volume in the first 24 hours, less need for blood transfusions, and less incidence of intraventricular hemorrhage. Delayed umbilical cord clamping has also been shown to increase the initial hematocrit and decrease the need for red blood cell (RBC) transfusions compared with no intervention in infants born between 27 and 33 weeks' gestation. However, a delay in cord clamping of 30-45 seconds may theoretically interfere with neonatal resuscitation. There have been few studies that addressed the active milking of the cord and its effect on neonatal resuscitation. Active milking of the umbilical cord towards the baby prior to clamping (rather than passive) should take less than 5 seconds to perform and should not interfere with neonatal resuscitation. Umbilical cord milking, as an alternative to delayed cord clamping, has been shown to increase the circulatory blood volume expressed as the hemoglobin value. Active milking of the cord prior to clamping, however, is not considered standard of care and only 1 Japanese randomized control study has reported that umbilical cord milking reduces the need for RBC transfusions, thus reducing the number of infants requiring a RBC transfusion as compared with control conditions. Our study aims to test the hypothesis that active milking of the umbilical cord will reduce the need for transfusion in preterm infants.

Interventions

  • PROCEDURE Umbilical Cord Milking

Trial Details

FieldValue
Enrollment Target 113 participants
Start Date 2009-09
Est. Completion 2011-11
Phase NA

Sponsor

Eastern Virginia Medical School

36 total trials

What the Registry Record Tells You About NCT01523769

The ClinicalTrials.gov registry entry for NCT01523769 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eastern Virginia Medical School, which has 36 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Umbilical Cord Milking is the first listed.

NCT01523769 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01523769 about?

NCT01523769 is a clinical study titled "Umbilical Cord Milking on the Reduction of Red Blood Cell Transfusion Rates in Infants". Delayed cord clamp of at least 30 seconds in neonates under 37 weeks has shown that these infants have higher circulating blood volume in the first 24 hours, less need for blood transfusions, and less incidence of intraventricular hemorrhage. Delayed umbilical cord clamping has also been shown to in...

What is the current status of trial NCT01523769?

This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2009-09. Estimated completion is 2011-11.

What interventions are being tested in trial NCT01523769?

The interventions under investigation include: Umbilical Cord Milking (PROCEDURE).

Who is sponsoring clinical trial NCT01523769?

This trial is sponsored by Eastern Virginia Medical School, which has 36 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.